{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:13:43Z","timestamp":1791832423710,"version":"4.3.4"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-OFIRG20nov-0123"],"award-info":[{"award-number":["MOH-OFIRG20nov-0123"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["MOH-OFYIRG24jul-0009"],"award-info":[{"award-number":["MOH-OFYIRG24jul-0009"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019579","name":"SingHealth","doi-asserted-by":"publisher","award":["AM\/TP100\/2025 (SRDUKAMR2500)"],"award-info":[{"award-number":["AM\/TP100\/2025 (SRDUKAMR2500)"]}],"id":[{"id":"10.13039\/100019579","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02347-0","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T14:36:39Z","timestamp":1752503799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Degradation of voltage-gated calcium channels: mechanisms and applications in neurological and cardiovascular diseases"],"prefix":"10.1186","volume":"23","author":[{"given":"Lihong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanruo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuck Wah","family":"Soong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"2347_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/wmts.102","volume":"3","author":"J Striessnig","year":"2014","unstructured":"Striessnig J, Pinggera A, Kaur G, Bock G, Tuluc P. L-type Ca(2+) channels in heart and brain. Wiley Interdiscip Rev Membr Transp Signal. 2014;3:15\u201338.","journal-title":"Wiley Interdiscip Rev Membr Transp Signal"},{"key":"2347_CR2","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1152\/physrev.00016.2013","volume":"94","author":"F Hofmann","year":"2014","unstructured":"Hofmann F, Flockerzi V, Kahl S, Wegener JW. L-type CaV1.2 calcium channels: from in vitro findings to in vivo function. Physiol Rev. 2014;94:303\u201326.","journal-title":"Physiol Rev"},{"key":"2347_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/8070","volume":"2","author":"E Bourinet","year":"1999","unstructured":"Bourinet E, Soong TW, Sutton K, Slaymaker S, Mathews E, Monteil A, Zamponi GW, Nargeot J, Snutch TP. Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nat Neurosci. 1999;2:407\u201315.","journal-title":"Nat Neurosci"},{"key":"2347_CR4","doi-asserted-by":"publisher","first-page":"10142","DOI":"10.1523\/JNEUROSCI.22-23-10142.2002","volume":"22","author":"TW Soong","year":"2002","unstructured":"Soong TW, DeMaria CD, Alvania RS, Zweifel LS, Liang MC, Mittman S, Agnew WS, Yue DT. Systematic identification of splice variants in human P\/Q-type channel alpha1(2.1) subunits: implications for current density and Ca2+-dependent inactivation. J Neurosci. 2002;22:10142\u201352.","journal-title":"J Neurosci"},{"key":"2347_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuron.2014.03.016","volume":"82","author":"BA Simms","year":"2014","unstructured":"Simms BA, Zamponi GW. Neuronal voltage-gated calcium channels: structure, function, and dysfunction. Neuron. 2014;82:24\u201345.","journal-title":"Neuron"},{"key":"2347_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00424-020-02395-0","volume":"472","author":"T Schneider","year":"2020","unstructured":"Schneider T, Neumaier F, Hescheler J, Alpdogan S. Cav2.3 R-type calcium channels: from its discovery to pathogenic de Novo CACNA1E variants: a historical perspective. Pflugers Arch. 2020;472:811\u20136.","journal-title":"Pflugers Arch"},{"key":"2347_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.biocel.2019.01.008","volume":"108","author":"N Weiss","year":"2019","unstructured":"Weiss N, Zamponi GW. T-type calcium channels: from molecule to therapeutic opportunities. Int J Biochem Cell Biol. 2019;108:34\u20139.","journal-title":"Int J Biochem Cell Biol"},{"key":"2347_CR8","doi-asserted-by":"crossref","unstructured":"Hu Z, Liang MC, Soong TW. Alternative splicing of L-type Ca(V)1.2 calcium channels: implications in cardiovascular diseases. Genes (Basel) 2017, 8.","DOI":"10.3390\/genes8120344"},{"key":"2347_CR9","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1124\/pr.114.009654","volume":"67","author":"GW Zamponi","year":"2015","unstructured":"Zamponi GW, Striessnig J, Koschak A, Dolphin AC. The physiology, pathology, and Pharmacology of Voltage-Gated calcium channels and their future therapeutic potential. Pharmacol Rev. 2015;67:821\u201370.","journal-title":"Pharmacol Rev"},{"key":"2347_CR10","doi-asserted-by":"publisher","first-page":"a003947","DOI":"10.1101\/cshperspect.a003947","volume":"3","author":"WA Catterall","year":"2011","unstructured":"Catterall WA. Voltage-gated calcium channels. Cold Spring Harb Perspect Biol. 2011;3:a003947.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2347_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nn.2712","volume":"14","author":"C Altier","year":"2011","unstructured":"Altier C, Garcia-Caballero A, Simms B, You H, Chen L, Walcher J, Tedford HW, Hermosilla T, Zamponi GW. The Cavbeta subunit prevents RFP2-mediated ubiquitination and proteasomal degradation of L-type channels. Nat Neurosci. 2011;14:173\u201380.","journal-title":"Nat Neurosci"},{"key":"2347_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature19321","volume":"537","author":"J Wu","year":"2016","unstructured":"Wu J, Yan Z, Li Z, Qian X, Lu S, Dong M, Zhou Q, Yan N. Structure of the voltage-gated calcium channel Ca(v)1.1 at 3.6 A resolution. Nature. 2016;537:191\u20136.","journal-title":"Nature"},{"key":"2347_CR13","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41422-022-00663-5","volume":"32","author":"X Yao","year":"2022","unstructured":"Yao X, Gao S, Yan N. Structural basis for pore Blockade of human voltage-gated calcium channel Ca(v)1.3 by motion sickness drug Cinnarizine. Cell Res. 2022;32:946\u20138.","journal-title":"Cell Res"},{"key":"2347_CR14","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1016\/j.cell.2023.10.007","volume":"186","author":"S Gao","year":"2023","unstructured":"Gao S, Yao X, Chen J, Huang G, Fan X, Xue L, Li Z, Wu T, Zheng Y, Huang J, et al. Structural basis for human Ca(v)1.2 Inhibition by multiple drugs and the neurotoxin calciseptine. Cell. 2023;186:5363\u2013e53745316.","journal-title":"Cell"},{"key":"2347_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41422-024-00940-5","volume":"34","author":"Z Li","year":"2024","unstructured":"Li Z, Cong Y, Wu T, Wang T, Lou X, Yang X, Yan N. Structural basis for different omega-agatoxin IVA sensitivities of the P-type and Q-type Ca(v)2.1 channels. Cell Res. 2024;34:455\u20137.","journal-title":"Cell Res"},{"key":"2347_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-021-03699-6","volume":"596","author":"S Gao","year":"2021","unstructured":"Gao S, Yao X, Yan N. Structure of human Ca(v)2.2 channel blocked by the painkiller Ziconotide. Nature. 2021;596:143\u20137.","journal-title":"Nature"},{"key":"2347_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41467-023-36260-2","volume":"14","author":"Y Gao","year":"2023","unstructured":"Gao Y, Xu S, Cui X, Xu H, Qiu Y, Wei Y, Dong Y, Zhu B, Peng C, Liu S, et al. Molecular insights into the gating mechanisms of voltage-gated calcium channel Ca(V)2.3. Nat Commun. 2023;14:516.","journal-title":"Nat Commun"},{"key":"2347_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-019-1801-3","volume":"576","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Huang G, Wu Q, Wu K, Li R, Lei J, Pan X, Yan N. Cryo-EM structures of Apo and antagonist-bound human Ca(v)3.1. Nature. 2019;576:492\u20137.","journal-title":"Nature"},{"key":"2347_CR19","doi-asserted-by":"crossref","unstructured":"He L, Yu Z, Geng Z, Huang Z, Zhang C, Dong Y, Gao Y, Wang Y, Chen Q, Sun L et al. Structure, gating, and pharmacology of human Ca(V)3.3 channel. Nat Commun. 2022;13:2084.","DOI":"10.1038\/s41467-022-29728-0"},{"key":"2347_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/s41422-024-00959-8","volume":"34","author":"J Huang","year":"2024","unstructured":"Huang J, Fan X, Jin X, Lyu C, Guo Q, Liu T, Chen J, Davakan A, Lory P, Yan N. Structural basis for human Ca(v)3.2 Inhibition by selective antagonists. Cell Res. 2024;34:440\u201350.","journal-title":"Cell Res"},{"key":"2347_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41422-024-00961-0","volume":"34","author":"L Ferron","year":"2024","unstructured":"Ferron L, Zamponi GW. A Tale of two calcium channels: structural Pharmacology of Cav2.1 and Cav3.2. Cell Res. 2024;34:401\u20132.","journal-title":"Cell Res"},{"key":"2347_CR22","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1146\/annurev-biochem-080411-121438","volume":"82","author":"D Atlas","year":"2013","unstructured":"Atlas D. The voltage-gated calcium channel functions as the molecular switch of synaptic transmission. Annu Rev Biochem. 2013;82:607\u201335.","journal-title":"Annu Rev Biochem"},{"key":"2347_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41583-020-0278-2","volume":"21","author":"AC Dolphin","year":"2020","unstructured":"Dolphin AC, Lee A. Presynaptic calcium channels: specialized control of synaptic neurotransmitter release. Nat Rev Neurosci. 2020;21:213\u201329.","journal-title":"Nat Rev Neurosci"},{"key":"2347_CR24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.tins.2006.08.006","volume":"29","author":"RM Evans","year":"2006","unstructured":"Evans RM, Zamponi GW. Presynaptic Ca2\u2009+\u2009channels\u2013integration centers for neuronal signaling pathways. Trends Neurosci. 2006;29:617\u201324.","journal-title":"Trends Neurosci"},{"key":"2347_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.brainresrev.2008.12.021","volume":"60","author":"GW Zamponi","year":"2009","unstructured":"Zamponi GW, Lewis RJ, Todorovic SM, Arneric SP, Snutch TP. Role of voltage-gated calcium channels in ascending pain pathways. Brain Res Rev. 2009;60:84\u20139.","journal-title":"Brain Res Rev"},{"key":"2347_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00424-009-0772-x","volume":"460","author":"GW Zamponi","year":"2010","unstructured":"Zamponi GW, Lory P, Perez-Reyes E. Role of voltage-gated calcium channels in epilepsy. Pflugers Arch. 2010;460:395\u2013403.","journal-title":"Pflugers Arch"},{"key":"2347_CR27","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1152\/physrev.00002.2006","volume":"86","author":"H Khosravani","year":"2006","unstructured":"Khosravani H, Zamponi GW. Voltage-gated calcium channels and idiopathic generalized epilepsies. Physiol Rev. 2006;86:941\u201366.","journal-title":"Physiol Rev"},{"key":"2347_CR28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00441-014-1936-3","volume":"357","author":"SM Berger","year":"2014","unstructured":"Berger SM, Bartsch D. The role of L-type voltage-gated calcium channels Cav1.2 and Cav1.3 in normal and pathological brain function. Cell Tissue Res. 2014;357:463\u201376.","journal-title":"Cell Tissue Res"},{"key":"2347_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuroscience.2019.09.041","volume":"421","author":"VS Alves","year":"2019","unstructured":"Alves VS, Alves-Silva HS, Orts DJB, Ribeiro-Silva L, Arcisio-Miranda M, Oliveira FA. Calcium signaling in neurons and glial cells: role of Cav1 channels. Neuroscience. 2019;421:95\u2013111.","journal-title":"Neuroscience"},{"key":"2347_CR30","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/00207454.2022.2115905","volume":"134","author":"A Sandoval","year":"2024","unstructured":"Sandoval A, Duran P, Corzo-Lopez A, Fernandez-Gallardo M, Munoz-Herrera D, Leyva-Leyva M, Gonzalez-Ramirez R, Felix R. The role of voltage-gated calcium channels in the pathogenesis of parkinson\u2019s disease. Int J Neurosci. 2024;134:452\u201361.","journal-title":"Int J Neurosci"},{"key":"2347_CR31","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.pharmthera.2011.11.006","volume":"133","author":"MJ Hurley","year":"2012","unstructured":"Hurley MJ, Dexter DT. Voltage-gated calcium channels and parkinson\u2019s disease. Pharmacol Ther. 2012;133:324\u201333.","journal-title":"Pharmacol Ther"},{"key":"2347_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2174\/1570159X20666220327211156","volume":"21","author":"BHM Correa","year":"2023","unstructured":"Correa BHM, Moreira CR, Hildebrand ME, Vieira LB. The role of Voltage-Gated calcium channels in basal ganglia neurodegenerative disorders. Curr Neuropharmacol. 2023;21:183\u2013201.","journal-title":"Curr Neuropharmacol"},{"key":"2347_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/1874467208666150507105235","volume":"8","author":"AF Breitenkamp","year":"2015","unstructured":"Breitenkamp AF, Matthes J, Herzig S. Voltage-gated calcium channels and autism spectrum disorders. Curr Mol Pharmacol. 2015;8:123\u201332.","journal-title":"Curr Mol Pharmacol"},{"key":"2347_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13041-020-00634-0","volume":"13","author":"X Liao","year":"2020","unstructured":"Liao X, Li Y. Genetic associations between voltage-gated calcium channels and autism spectrum disorder: a systematic review. Mol Brain. 2020;13:96.","journal-title":"Mol Brain"},{"key":"2347_CR35","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1093\/emboj\/cdg583","volume":"22","author":"S Moosmang","year":"2003","unstructured":"Moosmang S, Schulla V, Welling A, Feil R, Feil S, Wegener JW, Hofmann F, Klugbauer N. Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation. EMBO J. 2003;22:6027\u201334.","journal-title":"EMBO J"},{"key":"2347_CR36","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.19102\/icrm.2019.101006","volume":"10","author":"J Kushner","year":"2019","unstructured":"Kushner J, Ferrer X, Marx SO. Roles and regulation of Voltage-gated calcium channels in arrhythmias. J Innov Card Rhythm Manag. 2019;10:3874\u201380.","journal-title":"J Innov Card Rhythm Manag"},{"key":"2347_CR37","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.lfs.2017.12.033","volume":"194","author":"N Kumari","year":"2018","unstructured":"Kumari N, Gaur H, Bhargava A. Cardiac voltage gated calcium channels and their regulation by beta-adrenergic signaling. Life Sci. 2018;194:139\u201349.","journal-title":"Life Sci"},{"key":"2347_CR38","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1124\/mol.113.087155","volume":"84","author":"H Huang","year":"2013","unstructured":"Huang H, Yu D, Soong TW. C-terminal alternative splicing of CaV1.3 channels distinctively modulates their dihydropyridine sensitivity. Mol Pharmacol. 2013;84:643\u201353.","journal-title":"Mol Pharmacol"},{"key":"2347_CR39","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00424-020-02398-x","volume":"472","author":"KWZ Loh","year":"2020","unstructured":"Loh KWZ, Liang MC, Soong TW, Hu Z. Regulation of cardiovascular calcium channel activity by post-translational modifications or interacting proteins. Pflugers Arch. 2020;472:653\u201367.","journal-title":"Pflugers Arch"},{"key":"2347_CR40","doi-asserted-by":"crossref","unstructured":"Li Y, Li S, Wu H. Ubiquitination-Proteasome system (UPS) and autophagy two main protein degradation machineries in response to cell stress. Cells 2022, 11.","DOI":"10.3390\/cells11050851"},{"key":"2347_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd3321","volume":"10","author":"L Bedford","year":"2011","unstructured":"Bedford L, Lowe J, Dick LR, Mayer RJ, Brownell JE. Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov. 2011;10:29\u201346.","journal-title":"Nat Rev Drug Discov"},{"key":"2347_CR42","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1242\/jcs.183954","volume":"129","author":"M Akutsu","year":"2016","unstructured":"Akutsu M, Dikic I, Bremm A. Ubiquitin chain diversity at a glance. J Cell Sci. 2016;129:875\u201380.","journal-title":"J Cell Sci"},{"key":"2347_CR43","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ncb3358","volume":"18","author":"R Yau","year":"2016","unstructured":"Yau R, Rape M. The increasing complexity of the ubiquitin code. Nat Cell Biol. 2016;18:579\u201386.","journal-title":"Nat Cell Biol"},{"key":"2347_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fgene.2018.00029","volume":"9","author":"AJ George","year":"2018","unstructured":"George AJ, Hoffiz YC, Charles AJ, Zhu Y, Mabb AM. A comprehensive atlas of E3 ubiquitin ligase mutations in neurological disorders. Front Genet. 2018;9:29.","journal-title":"Front Genet"},{"key":"2347_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s43556-021-00043-2","volume":"2","author":"Q Yang","year":"2021","unstructured":"Yang Q, Zhao J, Chen D, Wang Y. E3 ubiquitin ligases: styles, structures and functions. Mol Biomed. 2021;2:23.","journal-title":"Mol Biomed"},{"key":"2347_CR46","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2021.10.027","volume":"82","author":"SM Lange","year":"2022","unstructured":"Lange SM, Armstrong LA, Kulathu Y. Deubiquitinases: from mechanisms to their Inhibition by small molecules. Mol Cell. 2022;82:15\u201329.","journal-title":"Mol Cell"},{"key":"2347_CR47","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12929-019-0569-y","volume":"26","author":"RH Chen","year":"2019","unstructured":"Chen RH, Chen YH, Huang TY. Ubiquitin-mediated regulation of autophagy. J Biomed Sci. 2019;26:80.","journal-title":"J Biomed Sci"},{"key":"2347_CR48","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1080\/15548627.2021.1984656","volume":"18","author":"J Zhou","year":"2022","unstructured":"Zhou J, Li XY, Liu YJ, Feng J, Wu Y, Shen HM, Lu GD. Full-coverage regulations of autophagy by ROS: from induction to maturation. Autophagy. 2022;18:1240\u201355.","journal-title":"Autophagy"},{"key":"2347_CR49","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1093\/hmg\/ddr048","volume":"20","author":"NC Chan","year":"2011","unstructured":"Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RL, Hess S, Chan DC. Broad activation of the ubiquitin-proteasome system by parkin is critical for mitophagy. Hum Mol Genet. 2011;20:1726\u201337.","journal-title":"Hum Mol Genet"},{"key":"2347_CR50","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nature12043","volume":"496","author":"SA Sarraf","year":"2013","unstructured":"Sarraf SA, Raman M, Guarani-Pereira V, Sowa ME, Huttlin EL, Gygi SP, Harper JW. Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature. 2013;496:372\u20136.","journal-title":"Nature"},{"issue":"Suppl 2","key":"2347_CR51","first-page":"S145","volume":"180","author":"SPH Alexander","year":"2023","unstructured":"Alexander SPH, Mathie AA, Peters JA, Veale EL, Striessnig J, Kelly E, Armstrong JF, Faccenda E, Harding SD, Davies JA, et al. The concise guide to PHARMACOLOGY 2023\/24: ion channels. Br J Pharmacol. 2023;180(Suppl 2):S145\u2013222.","journal-title":"Br J Pharmacol"},{"key":"2347_CR52","doi-asserted-by":"publisher","first-page":"39193","DOI":"10.1074\/jbc.M006467200","volume":"275","author":"C Seisenberger","year":"2000","unstructured":"Seisenberger C, Specht V, Welling A, Platzer J, Pfeifer A, Kuhbandner S, Striessnig J, Klugbauer N, Feil R, Hofmann F. Functional embryonic cardiomyocytes after disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. J Biol Chem. 2000;275:39193\u20139.","journal-title":"J Biol Chem"},{"key":"2347_CR53","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1523\/JNEUROSCI.1644-19.2020","volume":"40","author":"NN Zamora","year":"2020","unstructured":"Zamora NN, Cheli VT, Santiago Gonzalez DA, Wan R, Paez PM. Deletion of Voltage-Gated calcium channels in astrocytes during demyelination reduces brain inflammation and promotes Myelin regeneration in mice. J Neurosci. 2020;40:3332\u201347.","journal-title":"J Neurosci"},{"key":"2347_CR54","doi-asserted-by":"publisher","first-page":"10853","DOI":"10.1523\/JNEUROSCI.1770-16.2016","volume":"36","author":"VT Cheli","year":"2016","unstructured":"Cheli VT, Santiago Gonzalez DA, Namgyal Lama T, Spreuer V, Handley V, Murphy GG, Paez PM. Conditional deletion of the L-Type calcium channel Cav1.2 in oligodendrocyte progenitor cells affects postnatal myelination in mice. J Neurosci. 2016;36:10853\u201369.","journal-title":"J Neurosci"},{"key":"2347_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-021-01683-2","volume":"12","author":"S Navakkode","year":"2022","unstructured":"Navakkode S, Zhai J, Wong YP, Li G, Soong TW. Enhanced long-term potentiation and impaired learning in mice lacking alternative exon 33 of Ca(V)1.2 calcium channel. Transl Psychiatry. 2022;12:1.","journal-title":"Transl Psychiatry"},{"key":"2347_CR56","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.neuron.2018.03.017","volume":"98","author":"E Nanou","year":"2018","unstructured":"Nanou E, Catterall WA. Calcium channels, synaptic plasticity, and neuropsychiatric disease. Neuron. 2018;98:466\u201381.","journal-title":"Neuron"},{"key":"2347_CR57","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/19336950.2020.1807851","volume":"14","author":"PS Sridharan","year":"2020","unstructured":"Sridharan PS, Lu Y, Rice RC, Pieper AA, Rajadhyaksha AM. Loss of Cav1.2 channels impairs hippocampal theta burst stimulation-induced long-term potentiation. Channels (Austin). 2020;14:287\u201393.","journal-title":"Channels (Austin)"},{"key":"2347_CR58","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.1113\/JP270673","volume":"594","author":"ZD Kabir","year":"2016","unstructured":"Kabir ZD, Lee AS, Rajadhyaksha AM. L-type Ca(2+) channels in mood, cognition and addiction: integrating human and rodent studies with a focus on behavioural endophenotypes. J Physiol. 2016;594:5823\u201337.","journal-title":"J Physiol"},{"key":"2347_CR59","doi-asserted-by":"publisher","first-page":"775087","DOI":"10.3389\/fphar.2021.775087","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Yang H, He T, Zhang L, Liu C. Post-Translational modification of Cav1.2 and its role in neurodegenerative diseases. Front Pharmacol. 2021;12:775087.","journal-title":"Front Pharmacol"},{"key":"2347_CR60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.csbj.2022.11.049","volume":"21","author":"CA Crossley","year":"2023","unstructured":"Crossley CA, Rajani V, Yuan Q. Modulation of L-type calcium channels in alzheimer\u2019s disease: A potential therapeutic target. Comput Struct Biotechnol J. 2023;21:11\u201320.","journal-title":"Comput Struct Biotechnol J"},{"key":"2347_CR61","doi-asserted-by":"publisher","first-page":"109262","DOI":"10.1016\/j.neuropharm.2022.109262","volume":"220","author":"PJ Harrison","year":"2022","unstructured":"Harrison PJ, Husain SM, Lee H, Los Angeles A, Colbourne L, Mould A, Hall NAL, Haerty W, Tunbridge EM. CACNA1C (Ca(V)1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: advances from functional genomics and pharmacoepidemiology. Neuropharmacology. 2022;220:109262.","journal-title":"Neuropharmacology"},{"key":"2347_CR62","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.bbamem.2012.08.028","volume":"1828","author":"Z Buraei","year":"2013","unstructured":"Buraei Z, Yang J. Structure and function of the beta subunit of voltage-gated Ca(2)(+) channels. Biochim Biophys Acta. 2013;1828:1530\u201340.","journal-title":"Biochim Biophys Acta"},{"key":"2347_CR63","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1085\/jgp.200609485","volume":"128","author":"N Kanevsky","year":"2006","unstructured":"Kanevsky N, Dascal N. Regulation of maximal open probability is a separable function of Ca(v)beta subunit in L-type Ca2\u2009+\u2009channel, dependent on NH2 terminus of alpha1C (Ca(v)1.2alpha). J Gen Physiol. 2006;128:15\u201336.","journal-title":"J Gen Physiol"},{"key":"2347_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13041-021-00887-3","volume":"15","author":"A Tran-Van-Minh","year":"2022","unstructured":"Tran-Van-Minh A, De Waard M, Weiss N. Ca(v)beta surface charged residues contribute to the regulation of neuronal calcium channels. Mol Brain. 2022;15:3.","journal-title":"Mol Brain"},{"key":"2347_CR65","doi-asserted-by":"publisher","first-page":"1119729","DOI":"10.3389\/fcvm.2023.1119729","volume":"10","author":"KWZ Loh","year":"2023","unstructured":"Loh KWZ, Liu C, Soong TW, Hu Z. beta subunits of voltage-gated calcium channels in cardiovascular diseases. Front Cardiovasc Med. 2023;10:1119729.","journal-title":"Front Cardiovasc Med"},{"key":"2347_CR66","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1046\/j.1460-9568.2002.02168.x","volume":"16","author":"V Cornet","year":"2002","unstructured":"Cornet V, Bichet D, Sandoz G, Marty I, Brocard J, Bourinet E, Mori Y, Villaz M, De Waard M. Multiple determinants in voltage-dependent P\/Q calcium channels control their retention in the Endoplasmic reticulum. Eur J Neurosci. 2002;16:883\u201395.","journal-title":"Eur J Neurosci"},{"key":"2347_CR67","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1113\/jphysiol.2011.214247","volume":"589","author":"K Fang","year":"2011","unstructured":"Fang K, Colecraft HM. Mechanism of auxiliary beta-subunit-mediated membrane targeting of L-type (Ca(V)1.2) channels. J Physiol. 2011;589:4437\u201355.","journal-title":"J Physiol"},{"key":"2347_CR68","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nn0211-126","volume":"14","author":"S Kantamneni","year":"2011","unstructured":"Kantamneni S, Wilkinson KA, Henley JM. Ubiquitin regulation of neuronal excitability. Nat Neurosci. 2011;14:126\u20138.","journal-title":"Nat Neurosci"},{"key":"2347_CR69","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-023-06175-5","volume":"619","author":"Z Chen","year":"2023","unstructured":"Chen Z, Mondal A, Abderemane-Ali F, Jang S, Niranjan S, Montano JL, Zaro BW, Minor DL Jr. EMC chaperone-Ca(V) structure reveals an ion channel assembly intermediate. Nature. 2023;619:410\u20139.","journal-title":"Nature"},{"key":"2347_CR70","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41594-023-01013-8","volume":"30","author":"L Ferron","year":"2023","unstructured":"Ferron L, Gandini MA, Zamponi GW. Fighting pain: the structure of Gabapentin and its binding site in the Ca(v)alpha(2)delta subunit. Nat Struct Mol Biol. 2023;30:717\u20139.","journal-title":"Nat Struct Mol Biol"},{"key":"2347_CR71","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00018-011-0843-y","volume":"69","author":"BA Simms","year":"2012","unstructured":"Simms BA, Zamponi GW. Trafficking and stability of voltage-gated calcium channels. Cell Mol Life Sci. 2012;69:843\u201356.","journal-title":"Cell Mol Life Sci"},{"key":"2347_CR72","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1161\/CIRCRESAHA.111.248849","volume":"109","author":"J Wang","year":"2011","unstructured":"Wang J, Thio SS, Yang SS, Yu D, Yu CY, Wong YP, Liao P, Li S, Soong TW. Splice variant specific modulation of CaV1.2 calcium channel by galectin-1 regulates arterial constriction. Circ Res. 2011;109:1250\u20138.","journal-title":"Circ Res"},{"key":"2347_CR73","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1161\/CIRCULATIONAHA.117.031231","volume":"138","author":"Z Hu","year":"2018","unstructured":"Hu Z, Li G, Wang JW, Chong SY, Yu D, Wang X, Soon JL, Liang MC, Wong YP, Huang N, et al. Regulation of blood pressure by targeting Ca(V)1.2-Galectin-1 protein interaction. Circulation. 2018;138:1431\u201345.","journal-title":"Circulation"},{"key":"2347_CR74","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/s41419-018-0860-y","volume":"9","author":"Y Yuan","year":"2018","unstructured":"Yuan Y, Zhao J, Gong Y, Wang D, Wang X, Yun F, Liu Z, Zhang S, Li W, Zhao X, et al. Autophagy exacerbates electrical remodeling in atrial fibrillation by ubiquitin-dependent degradation of L-type calcium channel. Cell Death Dis. 2018;9:873.","journal-title":"Cell Death Dis"},{"key":"2347_CR75","doi-asserted-by":"publisher","first-page":"28063","DOI":"10.1074\/jbc.M704893200","volume":"282","author":"CA Carnes","year":"2007","unstructured":"Carnes CA, Janssen PM, Ruehr ML, Nakayama H, Nakayama T, Haase H, Bauer JA, Chung MK, Fearon IM, Gillinov AM, et al. Atrial glutathione content, calcium current, and contractility. J Biol Chem. 2007;282:28063\u201373.","journal-title":"J Biol Chem"},{"key":"2347_CR76","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1161\/HYPERTENSIONAHA.122.19103","volume":"79","author":"Z Hu","year":"2022","unstructured":"Hu Z, Zhang B, Lim LJY, Loh WZK, Yu D, Tan BWQ, Liang MC, Huang Z, Leo CH, Huang H, Soong TW. S-Nitrosylation-Mediated reduction of Ca(V)1.2 surface expression and open probability underlies attenuated vasoconstriction induced by nitric oxide. Hypertension. 2022;79:2854\u201366.","journal-title":"Hypertension"},{"key":"2347_CR77","doi-asserted-by":"publisher","first-page":"e12961","DOI":"10.1111\/acel.12961","volume":"18","author":"YJ Lai","year":"2019","unstructured":"Lai YJ, Zhu BL, Sun F, Luo D, Ma YL, Luo B, Tang J, Xiong MJ, Liu L, Long Y, et al. Estrogen receptor alpha promotes Cav1.2 ubiquitination and degradation in neuronal cells and in APP\/PS1 mice. Aging Cell. 2019;18:e12961.","journal-title":"Aging Cell"},{"key":"2347_CR78","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0968-0004(96)10031-1","volume":"21","author":"M Rechsteiner","year":"1996","unstructured":"Rechsteiner M, Rogers SW. PEST sequences and regulation by proteolysis. Trends Biochem Sci. 1996;21:267\u201371.","journal-title":"Trends Biochem Sci"},{"key":"2347_CR79","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1083\/jcb.200805063","volume":"184","author":"D Catalucci","year":"2009","unstructured":"Catalucci D, Zhang DH, DeSantiago J, Aimond F, Barbara G, Chemin J, Bonci D, Picht E, Rusconi F, Dalton ND, et al. Akt regulates L-type Ca2\u2009+\u2009channel activity by modulating Cavalpha1 protein stability. J Cell Biol. 2009;184:923\u201333.","journal-title":"J Cell Biol"},{"key":"2347_CR80","doi-asserted-by":"publisher","first-page":"50329","DOI":"10.1074\/jbc.M409436200","volume":"279","author":"P Liao","year":"2004","unstructured":"Liao P, Yu D, Lu S, Tang Z, Liang MC, Zeng S, Lin W, Soong TW. Smooth muscle-selective alternatively spliced exon generates functional variation in Cav1.2 calcium channels. J Biol Chem. 2004;279:50329\u201335.","journal-title":"J Biol Chem"},{"key":"2347_CR81","doi-asserted-by":"publisher","first-page":"8829","DOI":"10.1074\/jbc.M110.166520","volume":"286","author":"JS Rougier","year":"2011","unstructured":"Rougier JS, Albesa M, Abriel H, Viard P. Neuronal precursor cell-expressed developmentally down-regulated 4\u2013\u20091 (NEDD4-1) controls the sorting of newly synthesized Ca(V)1.2 calcium channels. J Biol Chem. 2011;286:8829\u201338.","journal-title":"J Biol Chem"},{"key":"2347_CR82","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbamcr.2013.03.024","volume":"1843","author":"M Scheffner","year":"2014","unstructured":"Scheffner M, Kumar S. Mammalian HECT ubiquitin-protein ligases: biological and pathophysiological aspects. Biochim Biophys Acta. 2014;1843:61\u201374.","journal-title":"Biochim Biophys Acta"},{"key":"2347_CR83","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41419-019-2142-8","volume":"10","author":"X Huang","year":"2019","unstructured":"Huang X, Chen J, Cao W, Yang L, Chen Q, He J, Yi Q, Huang H, Zhang E, Cai Z. The many substrates and functions of NEDD4-1. Cell Death Dis. 2019;10:904.","journal-title":"Cell Death Dis"},{"key":"2347_CR84","doi-asserted-by":"crossref","unstructured":"Kim YM, Kim HJ. Proteasome inhibitor MG132 is toxic and inhibits the proliferation of rat neural stem cells but increases BDNF expression to protect neurons. Biomolecules 2020, 10.","DOI":"10.3390\/biom10111507"},{"key":"2347_CR85","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","volume":"14","author":"M Mauthe","year":"2018","unstructured":"Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr M, Hijlkema KJ, Coppes RP, Engedal N, Mari M, Reggiori F. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14:1435\u201355.","journal-title":"Autophagy"},{"key":"2347_CR86","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1007\/s00424-014-1636-6","volume":"467","author":"JS Rougier","year":"2015","unstructured":"Rougier JS, Albesa M, Syam N, Halet G, Abriel H, Viard P. Ubiquitin-specific protease USP2-45 acts as a molecular switch to promote alpha2delta-1-induced downregulation of Cav1.2 channels. Pflugers Arch. 2015;467:1919\u201329.","journal-title":"Pflugers Arch"},{"key":"2347_CR87","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1161\/CIRCRESAHA.109.203620","volume":"105","author":"JP Bannister","year":"2009","unstructured":"Bannister JP, Adebiyi A, Zhao G, Narayanan D, Thomas CM, Feng JY, Jaggar JH. Smooth muscle cell alpha2delta-1 subunits are essential for vasoregulation by CaV1.2 channels. Circ Res. 2009;105:948\u201355.","journal-title":"Circ Res"},{"key":"2347_CR88","doi-asserted-by":"publisher","first-page":"2290807","DOI":"10.1080\/19336950.2023.2290807","volume":"18","author":"X Yao","year":"2024","unstructured":"Yao X, Gao S, Yan N. Structural biology of voltage-gated calcium channels. Channels (Austin). 2024;18:2290807.","journal-title":"Channels (Austin)"},{"key":"2347_CR89","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1038\/s41467-024-47116-8","volume":"15","author":"Y Wei","year":"2024","unstructured":"Wei Y, Yu Z, Wang L, Li X, Li N, Bai Q, Wang Y, Li R, Meng Y, Xu H, et al. Structural bases of inhibitory mechanism of Ca(V)1.2 channel inhibitors. Nat Commun. 2024;15:2772.","journal-title":"Nat Commun"},{"key":"2347_CR90","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1113\/JP270672","volume":"594","author":"A Pinggera","year":"2016","unstructured":"Pinggera A, Striessnig J. Ca(v) 1.3 (CACNA1D) L-type Ca(2+) channel dysfunction in CNS disorders. J Physiol. 2016;594:5839\u201349.","journal-title":"J Physiol"},{"key":"2347_CR91","doi-asserted-by":"publisher","first-page":"e12791","DOI":"10.1111\/gbb.12791","volume":"21","author":"M Lauffer","year":"2022","unstructured":"Lauffer M, Wen H, Myers B, Plumb A, Parker K, Williams A. Deletion of the voltage-gated calcium channel, Ca(V) 1.3, causes deficits in motor performance and associative learning. Genes Brain Behav. 2022;21:e12791.","journal-title":"Genes Brain Behav"},{"key":"2347_CR92","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nn.2694","volume":"14","author":"SM Baig","year":"2011","unstructured":"Baig SM, Koschak A, Lieb A, Gebhart M, Dafinger C, Nurnberg G, Ali A, Ahmad I, Sinnegger-Brauns MJ, Brandt N, et al. Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat Neurosci. 2011;14:77\u201384.","journal-title":"Nat Neurosci"},{"key":"2347_CR93","doi-asserted-by":"publisher","first-page":"42725","DOI":"10.1074\/jbc.M111.265207","volume":"286","author":"BZ Tan","year":"2011","unstructured":"Tan BZ, Jiang F, Tan MY, Yu D, Huang H, Shen Y, Soong TW. Functional characterization of alternative splicing in the C terminus of L-type CaV1.3 channels. J Biol Chem. 2011;286:42725\u201335.","journal-title":"J Biol Chem"},{"key":"2347_CR94","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.neuron.2011.11.022","volume":"73","author":"H Huang","year":"2012","unstructured":"Huang H, Tan BZ, Shen Y, Tao J, Jiang F, Sung YY, Ng CK, Raida M, Kohr G, Higuchi M, et al. RNA editing of the IQ domain in Ca(v)1.3 channels modulates their Ca(2)(+)-dependent inactivation. Neuron. 2012;73:304\u201316.","journal-title":"Neuron"},{"key":"2347_CR95","doi-asserted-by":"publisher","first-page":"e2203883119","DOI":"10.1073\/pnas.2203883119","volume":"119","author":"J Zhai","year":"2022","unstructured":"Zhai J, Navakkode S, Yeow SQZ, Krishna KK, Liang MC, Koh JH, Wong RX, Yu WP, Sajikumar S, Huang H, Soong TW. Loss of Ca(V)1.3 RNA editing enhances mouse hippocampal plasticity, learning, and memory. Proc Natl Acad Sci U S A. 2022;119:e2203883119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2347_CR96","first-page":"248","volume":"7","author":"CW Zhang","year":"2015","unstructured":"Zhang CW, Hang L, Yao TP, Lim KL. Parkin regulation and neurodegenerative disorders. Front Aging Neurosci. 2015;7:248.","journal-title":"Front Aging Neurosci"},{"key":"2347_CR97","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s40478-020-01062-w","volume":"8","author":"PMJ Quinn","year":"2020","unstructured":"Quinn PMJ, Moreira PI, Ambrosio AF, Alves CH. PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation. Acta Neuropathol Commun. 2020;8:189.","journal-title":"Acta Neuropathol Commun"},{"key":"2347_CR98","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1152\/jn.00287.2022","volume":"128","author":"L Grimaldo","year":"2022","unstructured":"Grimaldo L, Sandoval A, Duran P, Gomez Flores-Ramos L, Felix R. The ubiquitin E3 ligase parkin regulates neuronal Ca(V)1.3 channel functional expression. J Neurophysiol. 2022;128:1555\u201364.","journal-title":"J Neurophysiol"},{"key":"2347_CR99","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fnagi.2019.00382","volume":"11","author":"A Verma","year":"2019","unstructured":"Verma A, Ravindranath V. Ca(V)1.3 L-Type calcium channels increase the vulnerability of substantia Nigra dopaminergic neurons in MPTP mouse model of parkinson\u2019s disease. Front Aging Neurosci. 2019;11:382.","journal-title":"Front Aging Neurosci"},{"key":"2347_CR100","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4149\/gpb_2019004","volume":"38","author":"B Jurkovicova-Tarabova","year":"2019","unstructured":"Jurkovicova-Tarabova B, Lacinova L. Structure, function and regulation of Ca(V) 2.2\u00a0N-type calcium channels. Gen Physiol Biophys. 2019;38:101\u201310.","journal-title":"Gen Physiol Biophys"},{"key":"2347_CR101","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1073\/pnas.081089398","volume":"98","author":"M Ino","year":"2001","unstructured":"Ino M, Yoshinaga T, Wakamori M, Miyamoto N, Takahashi E, Sonoda J, Kagaya T, Oki T, Nagasu T, Nishizawa Y, et al. Functional disorders of the sympathetic nervous system in mice lacking the alpha 1B subunit (Cav 2.2) of N-type calcium channels. Proc Natl Acad Sci U S A. 2001;98:5323\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2347_CR102","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/cvr\/cvaa018","volume":"117","author":"D Zhang","year":"2021","unstructured":"Zhang D, Tu H, Wang C, Cao L, Hu W, Hackfort BT, Muelleman RL, Wadman MC, Li YL. Inhibition of N-type calcium channels in cardiac sympathetic neurons attenuates ventricular arrhythmogenesis in heart failure. Cardiovasc Res. 2021;117:137\u201348.","journal-title":"Cardiovasc Res"},{"key":"2347_CR103","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.1002\/1873-3468.13853","volume":"594","author":"H Saegusa","year":"2020","unstructured":"Saegusa H, Li X, Wang X, Kayakiri M, Tanabe T. Knockdown of microglial Cav2.2\u00a0N-type voltage-dependent Ca(2+) channel ameliorates behavioral deficits in a mouse model of parkinson\u2019s disease. FEBS Lett. 2020;594:2914\u201322.","journal-title":"FEBS Lett"},{"key":"2347_CR104","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1093\/emboj\/20.10.2349","volume":"20","author":"H Saegusa","year":"2001","unstructured":"Saegusa H, Kurihara T, Zong S, Kazuno A, Matsuda Y, Nonaka T, Han W, Toriyama H, Tanabe T. Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2\u2009+\u2009channel. EMBO J. 2001;20:2349\u201356.","journal-title":"EMBO J"},{"key":"2347_CR105","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neuropharm.2016.10.016","volume":"127","author":"E Bourinet","year":"2017","unstructured":"Bourinet E, Zamponi GW. Block of voltage-gated calcium channels by peptide toxins. Neuropharmacology. 2017;127:109\u201315.","journal-title":"Neuropharmacology"},{"key":"2347_CR106","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.2174\/0929867043363884","volume":"11","author":"GP Miljanich","year":"2004","unstructured":"Miljanich GP. Ziconotide: neuronal calcium channel blocker for treating severe chronic pain. Curr Med Chem. 2004;11:3029\u201340.","journal-title":"Curr Med Chem"},{"key":"2347_CR107","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1073\/pnas.0708930105","volume":"105","author":"J Hendrich","year":"2008","unstructured":"Hendrich J, Van Minh AT, Heblich F, Nieto-Rostro M, Watschinger K, Striessnig J, Wratten J, Davies A, Dolphin AC. Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand Gabapentin. Proc Natl Acad Sci U S A. 2008;105:3628\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2347_CR108","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/BST0380525","volume":"38","author":"CS Bauer","year":"2010","unstructured":"Bauer CS, Rahman W, Tran-van-Minh A, Lujan R, Dickenson AH, Dolphin AC. The anti-allodynic alpha(2)delta ligand Pregabalin inhibits the trafficking of the calcium channel alpha(2)delta-1 subunit to presynaptic terminals in vivo. Biochem Soc Trans. 2010;38:525\u20138.","journal-title":"Biochem Soc Trans"},{"key":"2347_CR109","doi-asserted-by":"publisher","first-page":"e2305215120","DOI":"10.1073\/pnas.2305215120","volume":"120","author":"K Gomez","year":"2023","unstructured":"Gomez K, Santiago U, Nelson TS, Allen HN, Calderon-Rivera A, Hestehave S, Rodriguez Palma EJ, Zhou Y, Duran P, Loya-Lopez S, et al. A peptidomimetic modulator of the Ca(V)2.2\u00a0N-type calcium channel for chronic pain. Proc Natl Acad Sci U S A. 2023;120:e2305215120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2347_CR110","doi-asserted-by":"publisher","first-page":"9598","DOI":"10.1074\/jbc.M110.195909","volume":"286","author":"D Waithe","year":"2011","unstructured":"Waithe D, Ferron L, Page KM, Chaggar K, Dolphin AC. Beta-subunits promote the expression of Ca(V)2.2 channels by reducing their proteasomal degradation. J Biol Chem. 2011;286:9598\u2013611.","journal-title":"J Biol Chem"},{"key":"2347_CR111","doi-asserted-by":"publisher","first-page":"20402","DOI":"10.1074\/jbc.M116.737270","volume":"291","author":"KM Page","year":"2016","unstructured":"Page KM, Rothwell SW, Dolphin AC. The CaVbeta subunit protects the I-II loop of the Voltage-gated calcium channel CaV2.2 from proteasomal degradation but not oligoubiquitination. J Biol Chem. 2016;291:20402\u201316.","journal-title":"J Biol Chem"},{"key":"2347_CR112","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s00424-014-1476-4","volume":"466","author":"MA Gandini","year":"2014","unstructured":"Gandini MA, Henriquez DR, Grimaldo L, Sandoval A, Altier C, Zamponi GW, Felix R, Gonzalez-Billault C. CaV2.2 channel cell surface expression is regulated by the light chain 1 (LC1) of the microtubule-associated protein B (MAP1B) via UBE2L3-mediated ubiquitination and degradation. Pflugers Arch. 2014;466:2113\u201326.","journal-title":"Pflugers Arch"},{"key":"2347_CR113","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4161\/19336950.2014.949162","volume":"8","author":"MA Gandini","year":"2014","unstructured":"Gandini MA, Sandoval A, Zamponi GW, Felix R. The MAP1B-LC1\/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels. Channels (Austin). 2014;8:452\u20137.","journal-title":"Channels (Austin)"},{"key":"2347_CR114","doi-asserted-by":"publisher","first-page":"e0185289","DOI":"10.1371\/journal.pone.0185289","volume":"12","author":"L Grimaldo","year":"2017","unstructured":"Grimaldo L, Sandoval A, Garza-Lopez E, Felix R. Involvement of parkin in the ubiquitin proteasome system-mediated degradation of N-type voltage-gated Ca2\u2009+\u2009channels. PLoS ONE. 2017;12:e0185289.","journal-title":"PLoS ONE"},{"key":"2347_CR115","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s00424-020-02429-7","volume":"472","author":"P Lory","year":"2020","unstructured":"Lory P, Nicole S, Monteil A. Neuronal Cav3 channelopathies: recent progress and perspectives. Pflugers Arch. 2020;472:831\u201344.","journal-title":"Pflugers Arch"},{"key":"2347_CR116","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1152\/physrev.00018.2002","volume":"83","author":"E Perez-Reyes","year":"2003","unstructured":"Perez-Reyes E. Molecular physiology of low-voltage-activated t-type calcium channels. Physiol Rev. 2003;83:117\u201361.","journal-title":"Physiol Rev"},{"key":"2347_CR117","doi-asserted-by":"publisher","first-page":"e0127572","DOI":"10.1371\/journal.pone.0127572","volume":"10","author":"M Watanabe","year":"2015","unstructured":"Watanabe M, Ueda T, Shibata Y, Kumamoto N, Shimada S, Ugawa S. Expression and regulation of Cav3.2 T-Type calcium channels during inflammatory hyperalgesia in mouse dorsal root ganglion neurons. PLoS ONE. 2015;10:e0127572.","journal-title":"PLoS ONE"},{"key":"2347_CR118","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.trsl.2021.01.002","volume":"234","author":"S Cai","year":"2021","unstructured":"Cai S, Gomez K, Moutal A, Khanna R. Targeting T-type\/CaV3.2 channels for chronic pain. Transl Res. 2021;234:20\u201330.","journal-title":"Transl Res"},{"key":"2347_CR119","doi-asserted-by":"crossref","unstructured":"Fayad SL, Ourties G, Le Gac B, Jouffre B, Lamoine S, Fruquiere A, Laffray S, Gasmi L, Cauli B, Mallet C et al. Centrally expressed Cav3.2 T-type calcium channel is critical for the initiation and maintenance of neuropathic pain. Elife 2022, 11.","DOI":"10.7554\/eLife.79018"},{"key":"2347_CR120","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1111\/bph.13906","volume":"175","author":"TP Snutch","year":"2018","unstructured":"Snutch TP, Zamponi GW. Recent advances in the development of T-type calcium channel blockers for pain intervention. Br J Pharmacol. 2018;175:2375\u201383.","journal-title":"Br J Pharmacol"},{"key":"2347_CR121","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuroscience.2025.05.011","volume":"577","author":"FTT Antunes","year":"2025","unstructured":"Antunes FTT, Zamponi GW. Exploring the role of Cav3.2 calcium channels in autism-like cognitive behavior induced by prenatal valproic acid exposure. Neuroscience. 2025;577:71\u20139.","journal-title":"Neuroscience"},{"key":"2347_CR122","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13041-020-00577-6","volume":"13","author":"RN Stringer","year":"2020","unstructured":"Stringer RN, Jurkovicova-Tarabova B, Huang S, Haji-Ghassemi O, Idoux R, Liashenko A, Souza IA, Rzhepetskyy Y, Lacinova L, Van Petegem F, et al. A rare CACNA1H variant associated with amyotrophic lateral sclerosis causes complete loss of Ca(v)3.2 T-type channel activity. Mol Brain. 2020;13:33.","journal-title":"Mol Brain"},{"key":"2347_CR123","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1080\/19336950.2016.1204497","volume":"10","author":"Y Rzhepetskyy","year":"2016","unstructured":"Rzhepetskyy Y, Lazniewska J, Blesneac I, Pamphlett R, Weiss N. CACNA1H missense mutations associated with amyotrophic lateral sclerosis alter Cav3.2 T-type calcium channel activity and reticular thalamic neuron firing. Channels (Austin). 2016;10:466\u201377.","journal-title":"Channels (Austin)"},{"key":"2347_CR124","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13041-019-0509-5","volume":"12","author":"IA Souza","year":"2019","unstructured":"Souza IA, Gandini MA, Zhang FX, Mitchell WG, Matsumoto J, Lerner J, Pierson TM, Zamponi GW. Pathogenic Cav3.2 channel mutation in a child with primary generalized epilepsy. Mol Brain. 2019;12:86.","journal-title":"Mol Brain"},{"key":"2347_CR125","doi-asserted-by":"publisher","first-page":"9681","DOI":"10.1074\/jbc.C400006200","volume":"279","author":"H Khosravani","year":"2004","unstructured":"Khosravani H, Altier C, Simms B, Hamming KS, Snutch TP, Mezeyova J, McRory JE, Zamponi GW. Gating effects of mutations in the Cav3.2 T-type calcium channel associated with childhood absence epilepsy. J Biol Chem. 2004;279:9681\u20134.","journal-title":"J Biol Chem"},{"key":"2347_CR126","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.neuron.2014.07.036","volume":"83","author":"A Garcia-Caballero","year":"2014","unstructured":"Garcia-Caballero A, Gadotti VM, Stemkowski P, Weiss N, Souza IA, Hodgkinson V, Bladen C, Chen L, Hamid J, Pizzoccaro A, et al. The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity. Neuron. 2014;83:1144\u201358.","journal-title":"Neuron"},{"key":"2347_CR127","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1093\/cvr\/cvt190","volume":"100","author":"SC Hsu","year":"2013","unstructured":"Hsu SC, Chang YT, Chen CC. Early growth response 1 is an early signal inducing Cav3.2 T-type calcium channels during cardiac hypertrophy. Cardiovasc Res. 2013;100:222\u201330.","journal-title":"Cardiovasc Res"},{"key":"2347_CR128","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/CIRCRESAHA.108.184051","volume":"104","author":"CS Chiang","year":"2009","unstructured":"Chiang CS, Huang CH, Chieng H, Chang YT, Chang D, Chen JJ, Chen YC, Chen YH, Shin HS, Campbell KP, Chen CC. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res. 2009;104:522\u201330.","journal-title":"Circ Res"},{"key":"2347_CR129","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1161\/CIRCULATIONAHA.121.054827","volume":"144","author":"D Zhao","year":"2021","unstructured":"Zhao D, Zhong G, Li J, Pan J, Zhao Y, Song H, Sun W, Jin X, Li Y, Du R, et al. Targeting E3 ubiquitin ligase WWP1 prevents cardiac hypertrophy through destabilizing DVL2 via Inhibition of K27-Linked ubiquitination. Circulation. 2021;144:694\u2013711.","journal-title":"Circulation"},{"key":"2347_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2015.09.004","volume":"88","author":"WA Basheer","year":"2015","unstructured":"Basheer WA, Harris BS, Mentrup HL, Abreha M, Thames EL, Lea JB, Swing DA, Copeland NG, Jenkins NA, Price RL, Matesic LE. Cardiomyocyte-specific overexpression of the ubiquitin ligase Wwp1 contributes to reduction in connexin 43 and arrhythmogenesis. J Mol Cell Cardiol. 2015;88:1\u201313.","journal-title":"J Mol Cell Cardiol"},{"key":"2347_CR131","doi-asserted-by":"crossref","unstructured":"Antunes FTT, Gandini MA, Garcia-Caballero A, Huang S, Ali MY, Gambeta E, Souza IA, Harding EK, Ferron L, Stray-Pedersen A et al. A pathological missense mutation in the deubiquitinase USP5 leads to insensitivity to pain. J Exp Med 2025, 222.","DOI":"10.1084\/jem.20241877"},{"key":"2347_CR132","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12990-015-0011-8","volume":"11","author":"VM Gadotti","year":"2015","unstructured":"Gadotti VM, Caballero AG, Berger ND, Gladding CM, Chen L, Pfeifer TA, Zamponi GW. Small organic molecule disruptors of Cav3.2 - USP5 interactions reverse inflammatory and neuropathic pain. Mol Pain. 2015;11:12.","journal-title":"Mol Pain"},{"key":"2347_CR133","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1021\/acschemneuro.1c00765","volume":"13","author":"A Garcia-Caballero","year":"2022","unstructured":"Garcia-Caballero A, Gadotti VM, Ali MY, Bladen C, Gambeta E, Van Humbeck JF, MacCallum JL, Zamponi GW. A synthetically accessible Small-Molecule inhibitor of USP5-Cav3.2 calcium channel interactions with analgesic properties. ACS Chem Neurosci. 2022;13:524\u201336.","journal-title":"ACS Chem Neurosci"},{"key":"2347_CR134","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1021\/acschemneuro.3c00083","volume":"14","author":"MY Ali","year":"2023","unstructured":"Ali MY, Gadotti VM, Huang S, Garcia-Caballero A, Antunes FTT, Jung HA, Choi JS, Zamponi GW. Icariside II, a Prenyl-Flavonol, alleviates inflammatory and neuropathic pain by inhibiting T-Type calcium channels and USP5-Cav3.2 interactions. ACS Chem Neurosci. 2023;14:1859\u201369.","journal-title":"ACS Chem Neurosci"},{"key":"2347_CR135","doi-asserted-by":"crossref","unstructured":"Patel KV, Gadotti VM, Garcia-Caballero A, Antunes FTT, Ali MY, Zamponi GW, Derksen DJ. Development of Tetrahydroquinoline-Based inhibitors for chronic pain. ACS Chem Neurosci 2024.","DOI":"10.1021\/acschemneuro.4c00316"},{"key":"2347_CR136","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12906-022-03732-9","volume":"22","author":"X Wang","year":"2022","unstructured":"Wang X, Li J, Liu L, Kan JM, Niu P, Yu ZQ, Ma C, Dong F, Han MX, Li J, Zhao DX. Pharmacological mechanism and therapeutic efficacy of Icariside II in the treatment of acute ischemic stroke: a systematic review and network Pharmacological analysis. BMC Complement Med Ther. 2022;22:253.","journal-title":"BMC Complement Med Ther"},{"key":"2347_CR137","doi-asserted-by":"crossref","unstructured":"Morgenstern TJ, Park J, Fan QR, Colecraft HM. A potent voltage-gated calcium channel inhibitor engineered from a nanobody targeted to auxiliary Ca(V)beta subunits. Elife 2019, 8.","DOI":"10.7554\/eLife.49253"},{"key":"2347_CR138","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1128\/MCB.00240-09","volume":"29","author":"HC Kim","year":"2009","unstructured":"Kim HC, Huibregtse JM. Polyubiquitination by HECT E3s and the determinants of chain type specificity. Mol Cell Biol. 2009;29:3307\u201318.","journal-title":"Mol Cell Biol"},{"key":"2347_CR139","doi-asserted-by":"publisher","first-page":"e2118129119","DOI":"10.1073\/pnas.2118129119","volume":"119","author":"L Sun","year":"2022","unstructured":"Sun L, Tong CK, Morgenstern TJ, Zhou H, Yang G, Colecraft HM. Targeted ubiquitination of sensory neuron calcium channels reduces the development of neuropathic pain. Proc Natl Acad Sci U S A. 2022;119:e2118129119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2347_CR140","doi-asserted-by":"crossref","unstructured":"Morgenstern TJ, Darko-Boateng A, Afriyie E, Shanmugam SK, Zhou X, Choudhury P, Desai M, Kass RS, Clarke OB, Colecraft HM. Ion channel inhibition by targeted recruitment of NEDD4-2 with divalent nanobodies. bioRxiv. 2024.","DOI":"10.1101\/2024.05.28.596281"},{"key":"2347_CR141","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1242\/jcs.091777","volume":"125","author":"MB Metzger","year":"2012","unstructured":"Metzger MB, Hristova VA, Weissman AM. HECT and RING finger families of E3 ubiquitin ligases at a glance. J Cell Sci. 2012;125:531\u20137.","journal-title":"J Cell Sci"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02347-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02347-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02347-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T12:26:59Z","timestamp":1757248019000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02347-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":141,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2347"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02347-0","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All the authors agree to publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"337"}}